Ignite Creation Date:
2024-05-06 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05252988
Status:
RECRUITING
Last Update Posted:
2023-12-15
First Post:
2022-02-02
Brief Title:
Three Antidiarrheal Strategies in HER2HR Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Spanish Breast Cancer Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-02
First Submit QC Date:
February 14 2022
Study First Post Date:
2022-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-11
Last Update Post Date:
2023-12-15
Last Update Post Date Type:
ACTUAL